DE3405172A1 - Erythromycinsalz der 2-(1,3-thiazolidin-3-yl)carbonylbenzoesaeure, verfahren zu seiner herstellung und es enthaltende pharmazeutische zusammensetzungen - Google Patents

Erythromycinsalz der 2-(1,3-thiazolidin-3-yl)carbonylbenzoesaeure, verfahren zu seiner herstellung und es enthaltende pharmazeutische zusammensetzungen

Info

Publication number
DE3405172A1
DE3405172A1 DE3405172A DE3405172A DE3405172A1 DE 3405172 A1 DE3405172 A1 DE 3405172A1 DE 3405172 A DE3405172 A DE 3405172A DE 3405172 A DE3405172 A DE 3405172A DE 3405172 A1 DE3405172 A1 DE 3405172A1
Authority
DE
Germany
Prior art keywords
salt
erythromycin
thiazolidin
acid
gram
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE3405172A
Other languages
German (de)
English (en)
Other versions
DE3405172C2 (US06653308-20031125-C00197.png
Inventor
Camillo Corvi Piacenza Mora
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CORVI CAMILLO SpA
Original Assignee
CORVI CAMILLO SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CORVI CAMILLO SpA filed Critical CORVI CAMILLO SpA
Publication of DE3405172A1 publication Critical patent/DE3405172A1/de
Application granted granted Critical
Publication of DE3405172C2 publication Critical patent/DE3405172C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DE3405172A 1983-02-16 1984-02-14 Erythromycinsalz der 2-(1,3-thiazolidin-3-yl)carbonylbenzoesaeure, verfahren zu seiner herstellung und es enthaltende pharmazeutische zusammensetzungen Granted DE3405172A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19621/83A IT1163108B (it) 1983-02-16 1983-02-16 Sale di eritromicina dell'acido benzoico-o-carboniltiazolidina,procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono

Publications (2)

Publication Number Publication Date
DE3405172A1 true DE3405172A1 (de) 1984-08-16
DE3405172C2 DE3405172C2 (US06653308-20031125-C00197.png) 1987-10-08

Family

ID=11159745

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3405172A Granted DE3405172A1 (de) 1983-02-16 1984-02-14 Erythromycinsalz der 2-(1,3-thiazolidin-3-yl)carbonylbenzoesaeure, verfahren zu seiner herstellung und es enthaltende pharmazeutische zusammensetzungen

Country Status (6)

Country Link
US (1) US4575496A (US06653308-20031125-C00197.png)
JP (1) JPS59161365A (US06653308-20031125-C00197.png)
DE (1) DE3405172A1 (US06653308-20031125-C00197.png)
FR (1) FR2540876B1 (US06653308-20031125-C00197.png)
GB (1) GB2135308B (US06653308-20031125-C00197.png)
IT (1) IT1163108B (US06653308-20031125-C00197.png)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133925A1 (en) * 2001-09-28 2003-07-17 Shawar Ribhi M. Monobactam compositions and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE766293A (en) * 1971-04-26 1971-09-16 Dechamps Pierre Antimicrobial erythromycin benzoate
US4264765A (en) * 1980-02-20 1981-04-28 Abbott Laboratories Salts of erythromycin A esters
FR2502627A1 (fr) * 1981-02-02 1982-10-01 Refarmed Sa Derives thioliques de l'erythromycine a activite therapeutique, procede de preparation et produits pharmaceutiques dans lesquels ils apparaissent
US4396613A (en) * 1981-12-14 1983-08-02 Eli Lilly And Company 23-Ester derivatives of DMT and method of using same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT *

Also Published As

Publication number Publication date
IT1163108B (it) 1987-04-08
JPH0374219B2 (US06653308-20031125-C00197.png) 1991-11-26
FR2540876B1 (fr) 1987-05-22
JPS59161365A (ja) 1984-09-12
GB2135308B (en) 1986-08-13
DE3405172C2 (US06653308-20031125-C00197.png) 1987-10-08
US4575496A (en) 1986-03-11
GB8403886D0 (en) 1984-03-21
GB2135308A (en) 1984-08-30
IT8319621A0 (it) 1983-02-16
FR2540876A1 (fr) 1984-08-17

Similar Documents

Publication Publication Date Title
DE3005164C2 (de) 1,1-Dioxopenicillanoyloxymethyl-6-(D-α-amino-α-phenylacetamido)-penicillanat, Verfahren zu seiner Herstellung und es enthaltendes Arzneimittel
DE2130113C3 (de) Gentamicin B, Gentamicin B1 und Gentamicin X, Verfahren zu deren Gewinnung und diese Gentamicine enthaltende pharmazeutische Zubereitungen
DE2738712A1 (de) Feste antibiotische zubereitungen
DE2409654A1 (de) Therapeutisches mittel
EP0864579B1 (de) Wismutsalze von Antibiotika der Moenomycin-Gruppe, Verfahren zu ihrer Herstellung, ihre Verwendung und solche Salze enthaltende Arzneimittel
DE60112581T2 (de) Zusammensetzungen zur Behandlung bakterieller Infektionen, welche ein Oxazolidinonderivat, Sulbactam und Ampicillin enthalten
DE2641388C3 (de) 3',4'-Didesoxykanamycin B-N-methansulfonsäuren und deren Alkalimetallsalze sowie diese Verbindungen enthaltende pharmazeutische Präparate
DE3780382T2 (de) Metall komplexe von n-methyl-11-aza-10-deoxy-10-dihydroerythromycin-a oder von 11-aza-10-deoxy-10-dihydroxyerythromycin-a, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von pharmazeutischen praeparaten.
DE2301540A1 (de) 5-0-(5-amino-5-deoxy-d-pentofuranosyl)n hoch 1-(4-amino-2-hydroxy-butyryl)-4-0(2,6-diamino-2,6-dideoxy-d-gluco-pyranosyl)2-deoxystreptamine
DE2509260C3 (de) a-(23,43,6-Penta-O-acetyl-D-gluconyl-thioureido)benzylpenicillin
DE2506622A1 (de) Antibiotisch wirksames heilmittel
DE2618009B2 (de) l-N-(a-Hydroxy-eo-aminoacyl)- derivate des 3'-Deoxykanamycin A und diese enthaltende Arzneimittel
DE3405172A1 (de) Erythromycinsalz der 2-(1,3-thiazolidin-3-yl)carbonylbenzoesaeure, verfahren zu seiner herstellung und es enthaltende pharmazeutische zusammensetzungen
DE60305741T2 (de) Neue halbsynthetische macrolidantibiotika der azalidreihe
DE69307894T2 (de) Ng-monomethyl-l-arginin-hydrochlorid-derivate und verfahren zu deren herstellung
DE2741431C3 (de) l-N-(L-4-Amino-2-hydroxybutyryl)-3'-desoxykanamycin-C, l-N-(L-4-Amino-2hydroxybutyryl)-3',4'-didesoxykanamycin-C und deren Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende antibakterielle Zusammensetzungen
DE2512587C3 (de) 1 -N-(L-4-Amino-2-hydroxybutyryl)-6' -N-alkylkanamycine A, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
DE69608260T2 (de) Wässrige spectinomycinborat-auflösung
DE1941036C (de) Tetracyclinlaktat
DE2436959C2 (de) Antibakterielle zusammensetzung mit einem gehalt an einer verbindung vom 3-fluor-d-alanin-typ und einer n-substituierten cycloserinverbindung
DE1068701B (de) Verfahren zur Herstellung von antibiotisch wirksamem Tetracyclinnatriumhexametaphosphat
DE1593015C3 (de) N.N'-Dimethyl-NJ'i'-di-detracyclinomethyl)-äthylendiamin und dessen Salze mit pharmakologisch unbedenklichen Mineral- und organischen Säuren sowie Verfahren zu deren Herstellung
DE2154027C3 (de) alpha- (N-2-Pyrimidylf ormamidlno) benzylpenicillin sowie dessen nichttoxische Salze, Verfahren zu seiner Herstellung sowie es enthaltende Arzneimittel
DE1543831C (de) Verfahren zur Herstellung von Erythromy cinglutamat
DE1745612C (de) 7 (N Chloralkyl ureido) cephalospo ransauren und deren Salze sowie ein Ver fahren zu deren Herstellung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: TUERK, D., DIPL.-CHEM. DR.RER.NAT. GILLE, C., DIPL

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee